Clinical Significance and Predictors of Community-Onset Pseudomonas aeruginosa Bacteremia

American Journal of Medicine

Volumn 121, Issue 8, 2008, Pages 709-714

  Cheong, Hae Suk ^a   Kang, Cheol In ^a   Wi, Yu Mi ^a   Kim, Eun Seok ^a   Lee, Jin Seo ^a   Ko, Kwan Soo ^a,b   Chung, Doo Ryeon ^a   Lee, Nam Yong ^a   Song, Jae Hoon ^a,b   Peck, Kyong Ran ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

Author keywords

Bacteremia; Community onset; Health care associated infection; Pseudomonas aeruginosa

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; CENTRAL VENOUS CATHETER; COMORBIDITY; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NEUTROPENIA; PANCREATOBILIARY DISEASE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SEPTIC SHOCK; URINARY TRACT INFECTION;

ADULT; BACTEREMIA; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; KOREA; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 48449100434     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.03.034     Document Type: Article

References (17)

1. Chatzinikolaou I., Abi-Said D., Bodey G.P., et al. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes. Arch Intern Med 160 4 (2000) 501-509
2. Lodise Jr. T.P., Patel N., Kwa A., et al. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: the impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother 51 10 (2007) 3510-3515
3. Kang C.I., Kim S.H., Kim H.B., et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 37 6 (2003) 745-751
4. Vidal F., Mensa J., Almela M., et al. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. Arch Intern Med 156 18 (1996) 2121-2126
5. Zelenitsky S.A., Harding G.K., Sun S., et al. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis. J Antimicrob Chemother 52 4 (2003) 668-674
6. McDonald J.R., Friedman N.D., Stout J.E., et al. Risk factors for ineffective therapy in patients with bloodstream infection. Arch Intern Med 165 3 (2005) 308-313
7. Friedman N.D., Kaye K.S., Stout J.E., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137 10 (2002) 791-797
8. Micek S.T., Lloyd A.E., Ritchie D.J., et al. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 49 4 (2005) 1306-1311
9. Kang C.I., Kim S.H., Park W.B., et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 49 2 (2005) 760-766
10. Chow J.W., and Yu V.L. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 11 1 (1999) 7-12
11. Lesens O., Methlin C., Hansmann Y., et al. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol 24 12 (2003) 890-896
12. Spanik S., Krupova I., Trupl J., et al. Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case-controlled study. J Infect Chemother 5 3 (1999) 180-184
13. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, 15th informational supplement (CLSI/NCCLS document M100-S15) (2005), CLSI, Wayne, PA
14. Todeschini G., Franchini M., Tecchio C., et al. Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 consecutive neutropenic patients with hematologic malignancies. Int J Infect Dis 3 2 (1998) 99-104
15. Giamarellou H. Prescribing guidelines for severe Pseudomonas infections. J Antimicrob Chemother 49 2 (2002) 229-233
16. Valles J., Rello J., Ochagavia A., et al. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 123 5 (2003) 1615-1624
17. Osmon S., Ward S., Fraser V.J., et al. Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. Chest 125 2 (2004) 607-616